T1CARE: A Trial of a Novel Intervention to Address Social Determinants of Health in Young Adults With Type 1 Diabetes
Part of paid clinical trials in New Haven, Connecticut.
- Sponsor
- Yale University
- Study ID
- NCT07059806
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 40 Years
- Healthy Volunteers
- Not accepted
Interventions
- T1CARE — BEHAVIORALThe intervention includes navigation by a Community Health Navigator (CHN), who will assess and help address patients' SDOH-related needs, coordinate care, and provide social support.
Study Details
Randomized controlled trial with a wait list control arm. Participants will be randomized 1:1 to T1CARE or wait list usual care arm. Participants will be recruited from the Yale Adult and Pediatric Diabetes Centers. Patients assigned to T1CARE will receive support from a Community Health Navigator at Project Access-New Haven.
Key Dates
- Start date
- Sep 5, 2025
- Status verified
- Jan 2026
- Primary completion
- Jun 30, 2027
- Completion
- Nov 30, 2027
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: T1CAREPatients who are randomized to the intervention arm will be contacted by the Community Health Navigator (CHN) from Project Access-New Haven (PA-NH) (PA-NH). The CHN will conduct an in-depth in-person intake interview to understand the patient's social and clinical need. Additional assessment will include access to insulin, diabetes technologies, and other supplies. The intake will be the basis for a personalized intervention that will respond to patient's unique needs. The initial interview will be audio-recorded to allow for qualitative data analysis. Outcomes will be measured at 6 months. Participants in the T1CARE group will have an option to join a social media platform in addition to receiving individualized support from the CHN.
- No Intervention: Standard CareParticipants in the control group will be receive standard screening for SDOH and standard diabetes care at their respective clinics.
Primary Outcome Measure
Number of participants with resolution of health-related social needs [ Time Frame: 6 months ]
Central Contacts
- Kasia J Lipska, MD203-500-3053
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Yale Adult Diabetes Center | New Haven | Connecticut | 06520 | - |
| Yale Children's Diabetes Center | New Haven | Connecticut | 06520 | - |
Find similar trials in New Haven, CT
By condition
By specialty
Related Studies
- Glu-COACH: a Peer-mentoring Intervention to Reduce Disparities in Continuous Glucose Monitor (CGM) UseRecruiting · Yale University · New Haven, Connecticut
- Registry for Stage 2 Type 1 DiabetesRecruiting · Sanofi · Baltimore, Maryland
- Pilot RCT: FQHC Intervention for Uptake of CGM in Low-Income Adults With T1DEnrolling By Invitation · University of Connecticut · Middletown, Connecticut
- A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 DiabetesPHASE1/PHASE2 · Recruiting · City of Hope Medical Center · San Francisco, California